MedTrace Logo

The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery

NCT00468598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2015-03-10

No results posted yet for this study

Summary

This survey has two aims. First, we would like to be informed about the health condition of our patients two years following heart surgery at University Hospital, Basel. Second, we are interested in determining whether a patient's long-term outcome can be predicted by the analysis of blood samples taken shortly after heart surgery.Troponin T, the blood parameter that we are interested in, is routinely assessed in the Intensive Care Unit. The purpose of this survey is to determine whether or not it is also possible to infer the long-term outcome from this blood parameter.

Conditions

  • Heart; Dysfunction Postoperative, Cardiac Surgery
  • Adverse Anesthesia Outcome

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Miodrag Filipovic, MD · Anesthesiology department, University Hospital of Basel

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-03-31
Completion
2013-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00468598 on ClinicalTrials.gov